EE494 Cost-Effectiveness Analysis of Axicabtagene Ciloleucel as a Second-Line Treatment for Diffuse Large B-Cell Lymphoma in China
Pei Wang(Sichuan University), Ming Hu(Ministry of Natural Resources), Nan Yang(General Sciences (United States)), Zhihao Zhao(Dalian Medical University), Xiao Ke(Taizhou First People's Hospital)
Cited by 0
Related Papers
A Knowledge-Enhanced Pretraining Model for Commonsense Story Generation
|Transactions of the Association for Computational Linguistics|2020|240
Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut Ugt
|Toxicology and Applied Pharmacology|2020|48
Chemopreventive effect of a mixture of Chinese Herbs (antitumor B) on chemically induced oral carcinogenesis
|Molecular Carcinogenesis|2011|43
Magnolia extract is effective for the chemoprevention of oral cancer through its ability to inhibit mitochondrial respiration at complex I
|Cell Communication and Signaling|2020|39